Hereditary nonpolyposis colorectal cancer laboratory findings
|
Hereditary Nonpolyposis Colorectal Cancer Microchapters |
|
Differentiating Hereditary Nonpolyposis Colorectal Cancer from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hereditary nonpolyposis colorectal cancer laboratory findings On the Web |
|
American Roentgen Ray Society Images of Hereditary nonpolyposis colorectal cancer laboratory findings |
|
FDA on Hereditary nonpolyposis colorectal cancer laboratory findings |
|
CDC on Hereditary nonpolyposis colorectal cancer laboratory findings |
|
Hereditary nonpolyposis colorectal cancer laboratory findings in the news |
|
Blogs on Hereditary nonpolyposis colorectal cancer laboratory findings |
|
Directions to Hospitals Treating Hereditary nonpolyposis colorectal cancer |
|
Risk calculators and risk factors for Hereditary nonpolyposis colorectal cancer laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]Ali Akram, M.B.B.S.[3]
Overview
Laboratory findings consistent with the diagnosis of hereditary nonpolyposis colorectal cancer, may include: positive germline testing for hereditary nonpolyposis colorectal cancer genes (MLH1, MSH2, MSH6, and PMS2), positive EPCAM gene testing, and elevated serum concentration of CEA and CA-125.
Laboratory Findings
Laboratory findings consistent with the diagnosis of hereditary nonpolyposis colorectal cancer, may include:[1]
References
- ↑ Lynch HT, Drescher K, Knezetic J, Lanspa S (2014). "Genetics, biomarkers, hereditary cancer syndrome diagnosis, heterogeneity and treatment: a review". Curr Treat Options Oncol. 15 (3): 429–42. doi:10.1007/s11864-014-0293-5. PMID 24827900.